Whitehawk Therapeutics (WHWK) EBITDA (2010 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly EBITDA came in at -$23.5 million in Q1 2026, down 54.57% year-on-year from -$51.8 million in Q1 2025, and up 5.48% on a QoQ basis from -$24.9 million in Q4 2025.
Whitehawk Therapeutics (WHWK) EBITDA (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of EBITDA data on file, last reported at -$23.5 million in Q1 2026.
- On a quarterly basis, EBITDA fell 54.57% year-over-year to -$23.5 million in Q1 2026; TTM through Mar 2026 was -$122.7 million, a 94.26% decrease from a year earlier, with the FY2025 full-year figure at -$114.4 million, down 69.59% from the prior year.
- EBITDA for Q1 2026 stood at -$23.5 million, up from -$24.9 million in the prior quarter.
- Over the last five years, EBITDA for WHWK reached as high as -$13.4 million in Q3 2024 and fell as low as -$54.7 million in Q2 2025.
- Historically, EBITDA has averaged -$20.0 million across 5 years, with a median of -$17.8 million in 2023.
- On a YoY basis, EBITDA climbed as much as 82.78% in 2022 and fell as far as 373.81% in 2022.
- Year by year, EBITDA stood at -$15.5 million in 2022, then declined by 14.49% to -$17.7 million in 2023, then decreased by 6.97% to -$18.9 million in 2024, then tumbled by 31.34% to -$24.9 million in 2025, then grew by 5.48% to -$23.5 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$23.5 million in Q1 2026, -$24.9 million in Q4 2025, and -$19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | -24.89 Mn |
| Sep 30, 2025 | -19.55 Mn |
| Jun 30, 2025 | -54.75 Mn |
| Mar 31, 2025 | -15.22 Mn |
| Dec 31, 2024 | -18.95 Mn |
| Sep 30, 2024 | -13.41 Mn |
| Jun 30, 2024 | -15.58 Mn |
| Mar 31, 2024 | -19.51 Mn |
| Dec 31, 2023 | -17.71 Mn |
| Sep 30, 2023 | -17.85 Mn |
| Jun 30, 2023 | -19.55 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -15.47 Mn |
| Sep 30, 2022 | -15.04 Mn |
| Jun 30, 2022 | -18.36 Mn |
| Mar 31, 2022 | -13.81 Mn |
| Dec 31, 2021 | -15.95 Mn |
| Sep 30, 2021 | -87.31 Mn |
| Jun 30, 2021 | -3.88 Mn |